Anzeige
Mehr »
Login
Sonntag, 21.04.2024 Börsentäglich über 12.000 News von 689 internationalen Medien
Breaking News: Voller Fokus auf NurExone Biologic!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1C017 | ISIN: FR0010907956 | Ticker-Symbol: CXT
Tradegate
18.04.24
11:57 Uhr
3,830 Euro
+0,030
+0,79 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
CARMAT Chart 1 Jahr
5-Tage-Chart
CARMAT 5-Tage-Chart
RealtimeGeldBriefZeit
3,7603,84020.04.
3,7603,83519.04.

Aktuelle News zur CARMAT Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
04.04.CARMAT Announces Its Participation in Several Scientific and Investor Conferences During the Second Quarter of 2024193Regulatory News: CARMAT (FR0010907956, ALCAR), designer and developer of the world's most advanced total artificial heart, aiming to provide a therapeutic alternative for people suffering from...
► Artikel lesen
25.03.Carmat jumps after agreement with financial creditors3
22.03.CARMAT Announces a Final Agreement With All Its Financial Creditors on New Repayment Terms for Its Bank Loans308Final maturity of all bank loans extended by at least 2 years Equitization of the loan contracted with the EIB to reduce its repayment in cash and optimize the Company's cash position Regulatory...
► Artikel lesen
22.02.CARMAT Provides Update on the Renegotiation of the Repayment Terms of Its Loans With Its Financial Creditors313Agreement in principle on the rescheduling of State-Guaranteed Loans ("PGE") obtained from BNP Paribas and Bpifrance Extension of the standstill granted by the EIB, BNP Paribas and Bpifrance...
► Artikel lesen
05.02.CARMAT: 2024 Financial Calendar353Regulatory News: CARMAT (FR0010907956, ALCAR), designer and developer of the world's most advanced total artificial heart, aimed at providing a therapeutic alternative for patients suffering from...
► Artikel lesen
29.01.CARMAT Announces the Completion of Its Capital Increase for a Gross Amount of €16.5 Million, Including the Exercise by the Lead Manager and Bookrunner of the Overallotment Option for an Amount of €1.5 Million381The funds raised represent 110% of the Initial Offer; the net amount of €14.9 million will contribute to the Company's short-term financing Together, demand and underwriting and guarantee...
► Artikel lesen
18.01.Carmat shares drop on discounted capital increase8
17.01.CARMAT Launches a Capital Increase of an Initial Amount of €15 Million as Part of Its Short-term Financing648This capital increase will be made by way of a public offering without preferential subscription rights The initial amount of the capital increase could be increased up to €17.25 million...
► Artikel lesen
15.01.Carmat drops on FY revenue below target, imminent capital increase6
15.01.Artificial heart maker Carmat to launch capital increase soon3
15.01.CARMAT reaches 50 artificial heart implants, eyes growth in 20243
15.01.Artificial heart maker Carmat to launch new capital increase soon1
15.01.CARMAT Achieves a Pivotal Year in 2023 by Reaching the Milestone of 50 Implants of the Aeson Artificial Heart and Presents Its Development Prospects38450 patients have benefited from CARMAT's Aeson® artificial heart since the first implant in 2013 Aeson® becomes an essential breakthrough innovation in the treatment of advanced biventricular...
► Artikel lesen
12.01.Carmat slips as it agrees to postpone EIB loan payment1
12.01.CARMAT announces a conditional agreement in principle with the EIB on new loan repayment terms, as part of the management of its short-term financing challenge640The implementation of this agreement would lead to a significant extension of the maturity date of each of three tranches of the loan Extension of the maturity date of the first tranche...
► Artikel lesen
05.01.CARMAT Announces the Approval of All Resolutions Supported by the Board of Directors at its Extraordinary General Meeting356Regulatory News: CARMAT (FR0010907956, ALCAR), designer and developer of Aeson®, the world's most advanced total artificial heart, aiming to provide a therapeutic alternative for people suffering...
► Artikel lesen
04.01.CARMAT's artificial heart used in first successful implant operation for cardiac tumour3
28.12.23CARMAT Announces a Software Enhancement Which Significantly Improves the Safety Profile of Its Aeson Artificial Heart423In compliance with regulations, the implementation of this modification gives rise to the publication of a "field safety notice". Its roll-out will begin over the next few days. Regulatory...
► Artikel lesen
11.12.23CARMAT Announces the First Implant of the Aeson Artificial Heart in a Patient Suffering From a Cardiac Tumor406This world first for Aeson® was achieved by teams at the Marie-Lannelongue Hospital in France as part of the EFICAS study The Marie-Lannelongue Hospital is one of the 8 French centers approved...
► Artikel lesen
05.12.23Carmat soars after saying it will meet 2024 production target13
Seite:  Weiter >>
30 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1